Paul Aisen
Physician · University of Southern California/Los Angeles General Medical Center
Credentials: · · ·
History
Internal Medicine
Research
Alzheimer s & Dementia · 2011 · 5,500 citations
Lecanemab in Early Alzheimer's Disease
New England Journal of Medicine · 2023 · 4,522 citations
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
The Lancet Neurology · 2010 · 3,717 citations
- RS
118 papers
115 papers
108 papers
61 papers
56 papers
52 papers
48 papers
- MR
47 papers
Grants
- 2025–2030
National Institute on Aging · R01
PI · $12.9M · Brigham and Women's Hospital
- 2017–2028
Alzheimer's Clinical Trials Consortium (ACTC)
National Institute on Aging · U24
Contact PI · $198.4M · University of Southern California
- 2004–2028
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
National Institute on Aging · U19
Project lead · $50.9M · Northern California Institute/Res/Edu
- 2025–2028
Life’s End Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study
National Institute on Aging · R01
PI · $4.1M · Medical University of South Carolina
Clinical trials
- 2023–2027
Alzheimer's Disease Neuroimaging Initiative 4
Principal investigator · Enrolling by invitation
University of Southern California
- 2019–2024
TRC-PAD Program: In-Clinic Trial-Ready Cohort
Principal investigator · Completed
University of Southern California
- 2017–2026
Alzheimer Prevention Trials (APT) Webstudy
Principal investigator · Recruiting
University of Southern California
- 2016–2024
Alzheimer's Disease Neuroimaging Initiative 3
Principal investigator · Completed
University of Southern California